Clinical Trials Directory

Trials / Completed

CompletedNCT01198015

Creatine Metabolism in Rett Syndrome

Metabolic Evaluation of Nutrition in Rett Syndrome: Creatine Metabolism

Status
Completed
Phase
Study type
Observational
Enrollment
13 (estimated)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
Female
Age
3 Years – 20 Years
Healthy volunteers
Not accepted

Summary

Rett syndrome (RTT) is an X-linked severe neurodevelopmental disorder. Despite their good appetite, many females with RTT meet the criteria for moderate to severe malnutrition. The pathological mechanism is barely understood. Although feeding difficulties may play a role in this, other constitutional factors as altered metabolic processes are suspected. Preliminary research showed elevated plasma creatine concentrations and increased urinary creatine/creatinine ratios in half of the RTT girls. The aim of this study is to confirm previous findings and examine the functionality of the creatine transporter in RTT girls. The investigators assume that previous findings will be confirmed, and are due to an altered functionality of the creatine transporter.

Conditions

Timeline

Start date
2010-08-01
Primary completion
2011-01-01
Completion
2011-01-01
First posted
2010-09-09
Last updated
2011-02-17

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01198015. Inclusion in this directory is not an endorsement.

Creatine Metabolism in Rett Syndrome (NCT01198015) · Clinical Trials Directory